it might be worth asking yourself: Am I building a painkiller, a vitamin, or a drug?
Investing in “drugs”
Sarah Tavel

There are 2 angles to that decision:

1- Users are becoming wiser and they’re evaluating the export/portability of their content before investing more in any given platform.

2- We as creators have an undeniable social responsibility of creating lasting value, which implies accepting that we can’t lock users in and allowing them to leave (and hope they come back) and competing on the basis of merit.

I for one refuse to build any product in the form of a drug.

One clap, two clap, three clap, forty?

By clapping more or less, you can signal to us which stories really stand out.